Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-06-23

FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's generic Nystatin and Triamcinolone Acetonide topical ointment (ANDA 208300) for the treatment of cutaneous candidiasis with inflammation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nystatin and Triamcinolone Acetonide topical ointment (Nystatin and Triamcinolone Acetonide)

Snippet

ORIG AP for NYSTATIN AND TRIAMCINOLONE ACETONIDE (NYSTATIN AND TRIAMCINOLONE ACETONIDE)